Across TCGA pan-cancer cohorts, VN1R67P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated VN1R67P data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher VN1R67P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VN1R67P expression acts as an unfavorable survival marker, although some lineages such as ACC and SKCM show a favorable association.
THCA, HNSC, and KIRP are the cancer types where VN1R67P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.